These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1957003)

  • 21. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
    Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: correlations with parotid dose and quality of life.
    Chen WC; Lai CH; Lee TF; Hung CH; Liu KC; Tsai MF; Wang WH; Chen H; Fang FM; Chen MF
    Oral Oncol; 2013 Jan; 49(1):42-8. PubMed ID: 22854066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of continuous hyperfractionated accelerated and conventionally fractionated radiotherapy on the parotid and submandibular salivary glands of rhesus monkeys.
    Price RE; Ang KK; Stephens LC; Peters LJ
    Radiother Oncol; 1995 Jan; 34(1):39-46. PubMed ID: 7792397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
    Nishimura Y; Nakamatsu K; Shibata T; Kanamori S; Koike R; Okumura M; Suzuki M
    Jpn J Clin Oncol; 2005 Jul; 35(7):375-9. PubMed ID: 15976068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of parotid gland irradiation in the development of severe hyposalivation (xerostomia) after intensity-modulated radiation therapy for head and neck cancer: Temporal patterns, risk factors, and testing the QUANTEC guidelines.
    Owosho AA; Thor M; Oh JH; Riaz N; Tsai CJ; Rosenberg H; Varthis S; Yom SH; Huryn JM; Lee NY; Deasy JO; Estilo CL
    J Craniomaxillofac Surg; 2017 Apr; 45(4):595-600. PubMed ID: 28256385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of parotid gland sparing on radiation damages of dental hard tissues.
    Hey J; Seidel J; Schweyen R; Paelecke-Habermann Y; Vordermark D; Gernhardt C; Kuhnt T
    Clin Oral Investig; 2013 Jul; 17(6):1619-25. PubMed ID: 23053706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
    Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scintigraphic assessment of early and late parotid gland function after radiotherapy for head-and-neck cancer: a prospective study of dose-volume response relationships.
    Roesink JM; Moerland MA; Hoekstra A; Van Rijk PP; Terhaard CH
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1451-60. PubMed ID: 15050323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parotid saliva composition during and after irradiation of head and neck cancer.
    Funegård U; Franzén L; Ericson T; Henriksson R
    Eur J Cancer B Oral Oncol; 1994 Jul; 30B(4):230-3. PubMed ID: 7524881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The function of the parotid gland following radiation therapy for head and neck cancer.
    Cheng VS; Downs J; Herbert D; Aramany M
    Int J Radiat Oncol Biol Phys; 1981 Feb; 7(2):253-8. PubMed ID: 7216860
    [No Abstract]   [Full Text] [Related]  

  • 31. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
    Burlage FR; Roesink JM; Kampinga HH; Coppes RP; Terhaard C; Langendijk JA; van Luijk P; Stokman MA; Vissink A
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):14-22. PubMed ID: 17869018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life.
    Eisbruch A; Dawson LA; Kim HM; Bradford CR; Terrell JE; Chepeha DB; Teknos TN; Anzai Y; Marsh LH; Martel MK; Ten Haken RK; Wolf GT; Ship JA
    Acta Otorhinolaryngol Belg; 1999; 53(3):271-5. PubMed ID: 10635407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parotid gland pathophysiology after mixed gamma and neutron irradiation of cancer patients.
    Anderson MW; Izutsu KT; Rice JC
    Oral Surg Oral Med Oral Pathol; 1981 Nov; 52(5):495-500. PubMed ID: 6946378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two-year longitudinal study of parotid salivary flow rates in head and neck cancer patients receiving unilateral neck parotid-sparing radiotherapy treatment.
    Henson BS; Eisbruch A; D'Hondt E; Ship JA
    Oral Oncol; 1999 May; 35(3):234-41. PubMed ID: 10621842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of local radiotherapy on kallikrein activity in saliva secreted by parotid gland in patients with head and neck cancers.
    Czokało M; Silko J; Topczewska E
    Rocz Akad Med Bialymst; 1996; 41(2):441-51. PubMed ID: 9020557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parotid gland function during and following radiotherapy of malignancies in the head and neck. A consecutive study of salivary flow and patient discomfort.
    Franzén L; Funegård U; Ericson T; Henriksson R
    Eur J Cancer; 1992; 28(2-3):457-62. PubMed ID: 1591063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional radiation dose susceptibility within the parotid gland: effects on salivary loss and recovery.
    Clark H; Hovan A; Moiseenko V; Thomas S; Wu J; Reinsberg S
    Med Phys; 2015 Apr; 42(4):2064-71. PubMed ID: 25832096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique.
    Amosson CM; Teh BS; Van TJ; Uy N; Huang E; Mai WY; Frolov A; Woo SY; Chiu JK; Carpenter LS; Lu HH; Grant WH; Butler EB
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):136-44. PubMed ID: 12694832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A model for predicting the dose to the parotid glands based on their relative overlapping with planning target volumes during helical radiotherapy.
    Millunchick CH; Zhen H; Redler G; Liao Y; Turian JV
    J Appl Clin Med Phys; 2018 Mar; 19(2):48-53. PubMed ID: 29105949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.